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Abstract
According to the World Health Organisation (WHO), the number of people with diabetes 
has risen to 422 million in 2014. Poorly managed diabetes leads to chronic hyper and/or 
hypoglycaemia, which are associated with neurological complications in type 1 (T1DM) 
and type 2 (T2DM) diabetes mellitus. Therefore, the primary target of diabetic treatment 
is to achieve a good glycaemic control (GC). In this chapter, we reviewed studies pub-
lished up to September 2017 about GC and cognitive development in diabetic children 
and adolescents, as well as the nutritional approaches used for the management of diabe-
tes in childhood, focusing on low glycaemic index (GI) diets. According to different stud-
ies, low GI diets effectively improve GC, which may reduce the risk of diabetes-related 
complications, such as cognitive dysfunction; however, the evidence is not sufficiently 
robust and the results are inconclusive. Despite the fact that, low GI diets are consis-
tent with healthy eating recommendations and should be encouraged in the prevention 
and nutritional management of diabetes. Further research is needed in diabetic children 
and adolescents at risk, especially well-designed long-term randomised controlled trials, 
with larger sample size, to determine the true value of low GI diets on long-term GC and 
diabetes prevention and management.
Keywords: diabetes, glycaemic index, blood glucose, neurodevelopment, cognitive 
performance, brain
1. Introduction
Diabetes mellitus (DM) is a complex, chronic endocrine disorder of carbohydrate metabolism 
resulting from a defect in insulin secretion, insulin action, or both and characterised by high 
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plasma glucose levels. Currently, it is a major contributor to morbidity and mortality and is 
becoming an epidemic together with obesity worldwide. In fact, according to the WHO, the 
number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014; 
furthermore, WHO projects that diabetes will be the seventh leading cause of death in 2030. 
However, the most worrying fact is that the number of people who suffer diabetes will reach 
over half a billion by 2030, becoming a major public health issue [1–5].
Diabetes is classified into four clinical categories, T1DM, T2DM, gestational diabetes mellitus 
(GDM) and other specific types of diabetes due to other causes, such as genetic defects in β-cell 
function, genetic defects in insulin action or diseases of the exocrine pancreas, among others 
[6]. The two primary forms of diabetes are T1DM and T2DM. T1DM or insulin-dependent 
DM is an autoimmune disorder characterised by insulin deficiency (an absolute or near total 
loss of insulin secretion) caused by the destruction of the insulin-producing pancreatic β-cells; 
the onset occurs typically during childhood or early adulthood, between the ages of 8 and 12, 
although it could happen at early ages. This form of diabetes is fatal in the absence of insulin 
replacement therapy. T1DM represents approximately 5–10% of all diagnosed cases of diabe-
tes [1, 3, 7–9], whereas T2DM or non-insulin-dependent diabetes, that accounts for 90–95% of 
all diagnosed cases. T2DM is characterised by decreased insulin sensitivity or insulin resis-
tance in peripheral tissues and relative insulin deficiency; this pathology is commonly associ-
ated with other metabolic disturbances like obesity, hypercholesterolemia, hypertension and 
other features of the metabolic syndrome. The prevalence of this disturbance is increasing and 
is been diagnosed at increasingly younger ages [1–3, 7, 8, 10].
Cognitive dysfunction is a well-established consequence of diabetes. There is extensive litera-
ture which has demonstrated that diabetes, its microvascular complications (nephropathy, 
neuropathy and retinopathy), and its management with insulin and other drugs can induce 
mild to moderately severe neurocognitive dysfunction as a consequence of structural and 
functional changes in the central nervous system (CNS), and it will be especially harmful in 
infancy and childhood when it is under development. It is known that glycaemic extremes 
(hyper and hypoglycaemia) affect brain development. The subjects who develop diabetes 
early in life (6–7 years old) have an elevated risk of mild to moderately severe dysfunction 
that affects virtually all cognitive domains, including learning and memory. However, if the 
onset of the diabetes is after this critical period, the neurocognitive dysfunction will be less 
severe and more restricted. But, although “later onset” subjects show lower scores compared 
with their healthy siblings on tests of intelligence, sustained attention, visuospatial skills, psy-
chomotor speed and executive functions, they show essentially normal learning and memory 
skills [9, 11]. Despite the fact that, poorly managed diabetes is associated with neurological 
complications [4, 12, 13].
Therefore, the primary target of diabetic treatment is to achieve a good GC measured by 
the glycated haemoglobin A1c (HbA1c). HbA1c reflects average glycaemia during the last 3 
months and has strong predictive value for diabetes-related complications. It has to be mea-
sured every 3 months in order to determine if patients´ glycaemic targets have been reached 
and maintained (HbA1c < 7.5% is recommended among all paediatric age-groups according 
to the American Diabetes Association; a lower goal <7% is recommended if it can be achieved 
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without excessive risk of hypoglycaemia) [4, 12, 13]. The optimal diet and macronutrient com-
position for diabetic children or adolescents remain controversial [14]. Initial reports support 
the use of the GI in diabetic management; GI is defined as ‘the incremental area under the blood 
glucose response curve elicited by a 50 g available carbohydrate of a test food expressed as a percentage 
of the response elicited by 50 g glucose in the same subject’ [15]. Recent criticisms of the GI focus on 
its validity, claiming that GI values are inaccurate and imprecise. Although, there are contro-
versial results in this matter and some research groups claim that there is insufficient evidence 
for the beneficial effects of GI diets, several studies have demonstrated that diets promoting 
low GI patterns effectively improved GC by reducing the occurrence of glycaemic extremes 
in subjects with diabetes [2, 4, 10, 14–20].
In this chapter, we reviewed the studies published up to September 2017 about GC and cogni-
tive development in diabetic children and adolescents. Furthermore, it has been performed a 
review of the nutritional approaches (Mediterranean diet, low GI diet, high-cereal fibre diet, car-
bohydrate exchange or low carbohydrate diets, low fat diet or diets rich in antioxidants) used for the 
management of diabetes, focused on low GI diets.
2. Early programming of diabetes
Recent studies highlight the importance of the intrauterine environment in women with pre-
existing diabetes and obesity on the long-term health of the offspring. Thus, an intrauterine 
environment that exposes the foetus to excess of glucose, lipids, inflammation, growth factors, 
and cytokines may promote adipogenesis, alter appetite regulation, adversely affect pancreas 
development, and modify mitochondrial function, resulting in long-term metabolic risk to the 
offspring. The metabolic intrauterine environment is considered a critical risk factor for the 
development of adult diabetes and cardiovascular diseases [21]. As a consequence, any harm 
during critical developmental windows induces permanent adaptive programming in key 
organs, leading to persistent alterations in gene expression through epigenetic mechanisms. 
Nutrition constitutes the most significant environmental factor, being both a risk factor and 
the key in the prevention and protection against different metabolic disorders later in life [22].
In utero programming seems to create a ‘metabolic memory’, considering that physiological 
anomalies during the gestational period are responsible for the onset of T2DM and obesity asso-
ciated with metabolic syndrome in the offspring at adulthood [23]. The periconceptional period 
has also been found as a critical period for nutritional effects on the ability of the foetus to 
respond to acute and chronic stressors, and for postnatal and adult metabolic health outcomes. 
It has been suggested that this period constitutes a critical time for nutritional effects on gene 
expression, with a potential preventive effect of postnatal risks related to prenatal maternal 
overconsumption and/or overweight, and DM or metabolic syndrome during pregnancy [22].
The association between poor psychosocial health, the risk of obesity and T2DM is well estab-
lished. DynaHEALTH EU project hypothesises that factors determining glucose metabolism 
and insulin sensitivity on one hand, and the neuroendocrine response resulting from expo-
sure to psychosocial stress on the other, should be incorporated as a single health indicator, 
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named ‘gluco-psychosocial axis’ (GPA) [24]. It is proposed that long-term GPA status could be 
established during developmental windows throughout early stages of life, via programming. 
The metabolic and psychosocial environments in early stages of life play an important role 
in the structural and functional development of the GPA components. Several studies have 
demonstrated the importance of the prenatal environment in determining long-term health 
and the ageing process [24].
Epidemiological evidence suggests impaired glucose metabolism begins much earlier in life 
[24]. According to clinical studies pre-pregnancy diabetes or GDM, together with maternal 
obesity, have been associated with higher risk in the offspring of developing obesity, insulin 
resistance and T2DM later in life [25]. Complications in the offspring might appear even with 
gestational glucose levels below the thresholds of GDM; even borderline high blood glucose 
levels increase the risk of infants of being large for gestational age, early adiposity rebound 
and higher prevalence of metabolic syndrome, especially if they become obese [22]. Infants 
born from mothers who developed DM before pregnancy had higher risk to develop obesity, 
higher blood glucose and HbA1c levels, as well as lower HDL cholesterol concentrations and 
were more prone to DM during childhood, compared to those infants born from mothers who 
developed DM after pregnancy [25]. Furthermore, different studies have demonstrated that 
both, GDM or pre-gestational diabetes are related to delayed brain maturation, deficiencies 
in fine/gross motor development, cognitive deficiencies, and higher risk to develop Attention 
Deficit Hyperactivity Disease (ADHD) in the offspring, especially when there was a bad con-
trol of the maternal illness (HbA1c > 7.5%) during pregnancy [26–28].
T2DM burden is currently increasing in young people; higher maternal body mass index 
(BMI) during pregnancy is associated with higher all-cause mortality, higher cardiovascu-
lar morbidity and mortality, and increased risk of T2DM among offspring [24]. Data from 
PREOBE project have demonstrated that infants born from obese mothers had significantly 
higher birth weight and waist circumference, and those born from mothers with GDM had 
higher waist/height index compared to the healthy controls [29]. Maftei et al. reported that 
maternal pre-pregnancy BMI is related to offspring’s insulin resistance at 9–10 years old, inde-
pendently of GDM, and gestational weight gain does not appear to affect insulin resistance in 
children [30]. Other studies, showed that both foetal hyperglycaemia and hyperinsulinaemia 
in GDM increase the obesity and diabetes rates in the offspring, independently of mater-
nal genetic influence [31]. Additionally, Westermeier et al., found that maternal obesity and 
neonatal insulin resistance are associated with long-term development of obesity, DM, and 
increased global cardiovascular risk in the offspring, involving deleterious mechanisms of 
intrauterine programming [32].
The DynaHEALTH EU project is testing how offspring’s diseases later in life and their own 
GPA status is established in early life in response to metabolic and stress factors and partly 
related to maternal GPA status in pregnancy [24].
Nevertheless, developmental programming in humans is not limited to the in utero environ-
ment, the nutritional status during post-natal period has a considerable impact on later life 
health. As well, gender differences in developmental programming have been largely ignored 
and it has been suggested that offspring responses to the early metabolic environment are highly 
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 sexually driven. This could be due to inherent gender differences in hypothalamic develop-
ment, or gender specificity of the adaptive response to environmental challenges. In fact, there 
is higher risk of T2DM in women who were exposed to high maternal BMI during foetal life. 
Thus, in the future it will be vital to take into account sex differences for the establishment of 
recommendations, health guidelines and in the design of new therapeutic interventions [24, 33].
Either pre-existing diabetes (T1DM/T2DM) or GDM are associated with macrosomia in the 
offspring. Alterations in macrosomic infants persist postnatally, leading to insulin resistance, 
obesity, diabetes and metabolic syndrome at adulthood [23]. Maternal programming creates 
a vicious cycle by which maternal diet, weight or glycaemic status can increase offspring sus-
ceptibility to metabolic disease. These offspring during their pregnancies will have their own 
children; also exposed to an adverse in utero environment, perpetuating the burden of such 
conditions to future generations (Figure 1) [25, 33].
The molecular mechanisms involved in foetal programming in diabetic women are far from 
understood [31]. It is essential that all diabetic women receive a proper management, including 
preconception counselling about weight management and weight loss (if they are overweight), 
Figure 1. Vicious cycle of metabolic disease perpetuation to future generations and critical windows for intervention. 
Adapted from Dearden and Ozanne [33].
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proper weight gain during pregnancy, the critical importance of optimising GC (HbA1c < 6.5), 
by self-monitoring blood glucose levels, medication (if needed), medical nutrition therapy (eat-
ing a healthy diet) and optimal individualised exercise [21, 31]. Therefore, prevention of foetal 
programming by tight GC will be essential in order to break the vicious cycle of obesity, diabetes 
and related-complications in future generations [31]. In order to develop effective intervention 
strategies, it is important to understand the programming effects of maternal nutrition during 
pregnancy and the post-natal period both separately and combined, as well as to define clearly 
the critical developmental periods in order to establish an appropriate time intervention [33].
3. Cognitive dysfunction related to diabetes
The negative effects of DM on retinal, renal, cardiovascular, and peripheral nervous systems 
are widely acknowledged, but less attention has received its effects on cognitive function and 
neurodevelopment. T1DM and T2DM are associated with reduced performance on numerous 
domains of cognitive function. The exact pathophysiology of cognitive dysfunction in dia-
betic patients is not well understood; nonetheless, vascular disease, hyper or hypoglycaemia, 
and insulin resistance seem to play significant roles [34].
Subjects with T1DM and T2DM can develop several microvascular (nephropathy, neuropa-
thy, retinopathy) and macrovascular (coronary heart disease, peripheral arterial disease, cere-
brovascular disease) complications that will contribute to cognitive dysfunction in adults; 
however, the major cause of mortality and morbidity in children with T1DM is the diabetic 
ketoacidosis, which cause cerebral injury along with haemorrhage or cerebral infarction in 
some cases, leading to cerebral edema (Table 1) [7, 8, 35].
Cognitive dysfunction in T1DM and T2DM share many similarities, but important differences 
do exist [7], specifically in the degree of cognitive dysfunction and in the manifestation of 
cognitive abnormalities [1]. Poorly managed diabetes due to chronic hyper and hypoglycae-
mia or elevated postprandial glucose may be common aetiological causes of the neurological 
complications of T1DM and T2DM or cognitive dysfunction [12, 36].
3.1. Type 1 diabetes
Different studies assessing cognition in children and adolescents with an early onset of dia-
betes (EOD) (6–7 years) have shown higher risk of developing more severe cognitive deficits, 
especially impairments in memory, learning, intelligence and verbal fluency/language [36, 37], as 
well as in attention, executive function [38], psychomotor speed [9], slowing of information process-
ing, problem solving, visuoconstruction, visual perception and mental flexibility [7].
Patients with T1DM often perform within normal cognitive range; however, they may per-
form more poorly on some cognitive tasks compared to non-diabetic control subjects, such as 
executive functions, short-term memory, psychomotor efficiency and measure of mental efficiency, 
which predispose for more rapid deterioration of cognitive function later in life [1]. Kodl and 
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Seaquist found different cognitive domains negatively affected in T1DM, specifically informa-
tion processing*, psychomotor efficiency*, attention*, memory, learning, problem solving, motor speed, 
vocabulary, general intelligence, visuoconstruction*, visual perception, somatosensory examination, 
motor strength, mental flexibility* and executive function. According to the authors the domains 
marked by asterisks have strong supporting data [34].
Metabolic factors • Chronic exposure to hyperglycaemia [1]
• Acute exposure to hypoglycaemia [11]
• Recurrent exposure to hypoglycaemia [1]
• Increased plasmatic concentration of AGEs [34]
CV factors • Microvascular complications (nephropathy, neuropathy, retinopathy) [8]
• Macrovascular complications (coronary heart, peripheral arterial and cerebrovascular diseases) [8]
• Endothelial dysfunction [17]
• Increased inflammatory markers (C-reactive protein, α-1-antichymotrypsin, interleukin-6 and 
intercellular adhesion molecule 1) [34]
• Changes in blood–brain barrier permeability
• Reduced fibrinolysis [14]
• Dyslipidemia (increased total cholesterol, LDL-c and triglycerides, and reduced HDL-c) [14]
Hypertension [1]
Endocrine factors • Insulin resistance [34]
• Hyperinsulinaemia
• Impaired HPA axis activity [12]
• Absence of C-Peptide [34]
• Increased antidiuretic hormone
Hyperleptinaemia
CNS factors • Genetic predisposition (Absence of Apoε4 Allele) [34]
• Amyloid disposition
• Increased oxidative stress [11]
• Changes in neuronal calcium homeostasis
• Depression and anxiety [2, 12]
• Disrupted myelination [11]
• Increased apoptosis in oligodendrocyte precursor cells [11]
• Dysfunctional synaptic plasticity [1]
Disease onset • Early onset diabetes (6–7 years old) [9]
Advanced glycation end products, AGEs; cardiovascular, CV; central nervous system, CNS; high density lipoprotein 
cholesterol, HDL-c; hypothalamic-pituitary-adrenal, HPA; low density lipoprotein cholesterol, LDL-c. Adapted from 
McCrimmon RJ, Ryan CM, Frier BM. Lancet, 2012 [7].
Table 1. Factors that contribute to the development of cognitive dysfunction in diabetic patients.
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Figure 2. Effect of glycaemic extremes on the development of congestive dysfunction.
Neuroimaging studies have found morphological abnormalities, cortical atrophy, lower grey 
matter volume and density in left temporal-occipital junction, white matter hyper-intensities 
and reduced white matter densities, concretely white matter microstructural deficits, as well as 
neuroanatomical changes in the hippocampal region. However, other studies did not find volu-
metric changes in the hippocampus [12, 36, 37]. In fact, Ho et al., have reported that measuring 
subfields of the hippocampus with high resolution magnetic resonance imaging may provide a 
way to specifically target the neurogenic regions of the hippocampus and may show different 
effects of diabetes on different parts of the hippocampus. It should be noted that studies car-
ried out in rodents with T1DM have shown reductions in hippocampal cell proliferation and 
survival, leading to learning and memory deficits compared to control rodents (Figure 2) [3].
Additionally, glycaemic extremes (hyper and hypoglycaemia) affect brain development. 
Severe hypoglycaemia during a lifetime exposure decreases lateral temporal–parietal-occip-
ital grey matter volume, whereas after 2 years with T1DM showed a greater reduction in 
the regional white matter volume in the precuneus/cuneus region [11]. Furthermore, severe 
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hypoglycaemia harms neurons in cerebral cortex, medial temporal region, including hip-
pocampus, basal ganglia and brain stem with unknown individual consequences [36]. 
Hypoglycaemic episodes in T1DM children lead to significant declines in verbal abilities, mem-
ory skills and ability to organise and recall information. Severe hypoglycaemia may result in per-
sistent electroencephalography (EEG) changes, with 80% of EEG abnormalities observed in 
diabetic children with history of severe hypoglycaemia compared with 30% of abnormalities 
in diabetic subjects without severe hypoglycaemia and 24% in healthy control children [39]. 
In presence of severe hypoglycaemia in T1DM, children show mildly reduced intelligence 
quotient (IQ), as well as adverse effects in general, verbal and performance IQ [40].
Children and adults with T1DM have worse performance in executive function, full IQ 
and motor speed; in presence of hyperglycaemia negative effects on memory function were 
observed in children. Moreover, higher HbA1c levels were associated with worse motor 
speed and psychomotor efficiency [41]. Additionally, chronic hyperglycaemia has been associ-
ated with reductions in grey matter volume and multiple posterior brain regions, includ-
ing the cerebellum. Adolescents with three or more symptomatic hyperglycaemic episodes 
showed reductions in white matter integrity, specifically in superior parietal lobule, corpus 
callosum, posterior limb of the internal capsule, and grey matter integrity, concretely in 
thalamus and putamen, whereas children (4–10 years old) showed microstructural abnor-
malities in white matter with lower IQ scores [40]. A lifetime exposure to hyperglycaemia 
reduces occipital/parietal grey and matter volume; after 2 years with T1DM, a reduction 
in the whole brain grey matter has been observed [11]. Large effects have been observed 
in T1DM patients regarding visuospatial ability, motor speed, writing, sustained attention and 
reading [40, 42].
It is worth noting that a late onset of diabetes (LOD) entails several cognitive dysfunctions, 
although these impairments are less severe compared to those subjects with EOD. In subjects 
with a LOD, it has been found lower overall cognition, intelligence, visual learning and memory, 
motor speed and visual motor integration, sustained attention and executive function compared to 
their healthy siblings [9, 38].
Finally, several studies have shown that gender influences neurocognitive function in 
T1DM. In a study with children and adolescents (aged 7–16 years), boys presented decline in 
verbal intelligence, which was correlated with worse GC. This was not seen in girls of similar 
ages. It should be noted that most human studies do not distinguish between genders when 
describing results of neurocognitive testing [34].
3.2. Type 2 diabetes
The prevalence of childhood obesity has increased dramatically worldwide, leading to a 
variety of health problems, including T2DM, which previously was seen only in adults. The 
Centres for Disease Control (CDC) and Prevention foresee that the prevalence of T2DM in 
those under 20 years of age will quadruple in 40 years, assuming a 2.3% annual increase [6]. 
In the United States, up to 1 in 3 new cases of diabetes diagnosed in subjects younger than 
18 years old is T2DM, occurring most commonly in children and adolescents between 10 and 
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19 years of age [43]. It is difficult to distinguish between T1DM and T2DM in children, given 
the current obesity epidemic worldwide. The rapid emergence of childhood T2DM means 
that health professionals have to treat a disease in children, which previously was encoun-
tered only in adults. This represents several challenges, because most of diabetes education 
materials are designed and directed to children with T1DM, but not to T2DM and probably 
obese patients. Another problem is that most medications used for T2DM have been tested 
for safety and efficacy in subjects older than 18 years old, because ethical reasons. Therefore, 
there is scarce scientific data for optimal management of children with T2DM [6, 43].
The comorbidities, such as obesity, hypertension and dyslipidaemia, may be present at the 
time of diagnosis in youth with T2DM, which contribute to the severity of the disease. The 
cause of diabetes-related cognitive dysfunction is difficult to establish, because of the preva-
lence of several comorbidities in the same individual, which might affect cognitive function 
[6, 7].
Lamport et al. [44], performed a systematic review in adults, concluding that T2DM is associ-
ated with cognitive impairments. In the present longitudinal review we found many stud-
ies relating an accelerated cognitive decline in adults with T2DM; however, it is difficult to 
conclude that these reported cognitive impairments are independently associated to abnor-
malities in glucose tolerance or due to the associated comorbidities present in these patients 
(cerebrovascular and cardiovascular diseases, obesity, hypertension and hypercholesterol-
emia) [44]. Some studies suggest that cognitive performance does not differ in T2DM subjects 
in relation to non-diabetic controls when it is taken into account the influence of age, premor-
bid IQ, BMI and depression [1]. Unlike the studies in T1DM patients, most studies suggest 
that T2DM subjects experience cognitive decline. T2DM most often is associated with deficits 
in cognitive domains, declarative memory, attention and executive function, alterations also seen 
in children and adolescents with Metabolic Syndrome or obesity and glycaemic disorders 
[45, 46]. The GC, the disease duration and cerebrovascular complications are considered risk 
factors that influence the magnitude of the cognitive decline [12]. Learning and memory defi-
cits are the cognitive abnormalities that most clearly differentiate patients with T2DM from 
T1DM patients [7].
Kodl and Seaquist, established that the cognitive domains that are negatively affected 
in adults with T2DM are memory* (verbal memory, visual retention, working memory, immedi-
ate recall, delayed recall), psychomotor speed*, executive function*, processing speed, complex motor 
function, verbal fluency, attention and it seems to be related with the development of diabetes. 
According to the authors, the domains marked by asterisks have strong supporting data [34]. 
Additionally, Sweat et al., in a study carried out in 162 adolescents (aged 19.53 ± 1.53 years), 
found that obese adolescents showed slower processing speed maintaining equivalent executive 
functioning compared with their healthy siblings [46]. Whereas, a recent systematic review 
performed Barkin et al., showed a consistent inverse association between obesity and executive 
function in children and adolescents, emphasising that in future research is necessary to use 
a standardised method of executive function measurement in order to establish causality with 
obesity and develop new and more effective intervention strategies [47].
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Neuroimaging studies have shown deficits in hippocampal-based cognitive performance, 
which may be attributed to changes in brain structure and volume, leading to deficits in 
attention, learning and memory [1]. T2DM subjects have similar morphological abnormali-
ties than T1DM patients, such as cortical atrophy and white matter lesions. Moreover, it has 
been shown a reduction in the microstructural integrity of white matter and grey matter. The 
reductions in grey matter volumes have been observed in the prefrontal cortex, amygdala and 
hippocampus [12]. Additionally, greater cortical atrophy, more lesions in deep white matter 
and hippocampal (susceptible to acute metabolic changes, such as hypoglycaemia) atrophy, 
leading to impairments in immediate memory, have been observed (Figure 2) [7].
Hippocampal atrophy is one of the neuroanatomical characteristics that differs between peo-
ple with T1DM and T2DM, both have reduced grey matter density and white matter lesions. 
Nevertheless, cortical atrophy is more pronounced in T2DM, possibly because the sub-
jects are older on average. Moreover, the hippocampus is more affected in T2DM, is unclear 
why, because this area is susceptible to acute metabolic change, which is more prominent in 
T1DM. This suggests that age, sex, the associated comorbidities and the presence of macrovas-
cular disease or insulin resistance might be important risk factors for hippocampal atrophy 
(Figure 2). T2DM subjects perform worse than healthy control on learning and memory tests, 
unlike those with T1DM, who rarely have deficits in these domains [7]. However, the results 
are inconclusive, because other studies have found deficits in learning and memory in T1DM 
patients, but Kodl and Seaquist confirmed that there is no strong evidence to suggest this [34].
4. Glycaemic index and dietetic management in diabetic children and 
adolescents
At present, nutritional interventions, physical activity and weight control remain the main 
pillars of effective diabetes management. Despite modern approaches to intensive insulin 
therapy and other drugs for the management of diabetes, dietary management remains as 
the main important action of diabetes treatment [48]. There is not an ideal nutritional inter-
vention for the management of diabetes. A poor GC in subjects with T1DM and T2DM has 
been related with the onset of diabetes complications. Therefore, it is vital to develop new 
strategies in order to maintain a good GC. Current standards for diabetes management reflect 
the need to lower glucose as safely as possible, without increasing the risk or hypoglycaemic 
episodes. It should receive special consideration the risk of hypoglycaemia in young children 
(aged <6 years or EOD), because usually they are unable to recognise and/or manage the 
symptoms. This is called ‘hypoglycaemia unawareness’ [6].
There are different dietetic approaches aimed at the improvement of the GC in children and 
adolescents with T1DM and T2DM, among them it is worth noting low GI diets, diets rich in 
antioxidants, carbohydrate exchange diets, high-cereal fibre diet, traditional Mediterranean-
style dietary pattern, low carbohydrate Mediterranean style diet, low carbohydrate diets and 
low fat diets.
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Although there are no long-term intervention studies looking at the effects of a low GI diet 
on diabetes prevention, there is a large body of evidence from animal models, clinical trials 
and epidemiologic studies that demonstrates the benefits of a low GI diet in the prevention 
and management of diabetes. Low GI diets in subjects with T1DM and T2DM improve blood 
glucose control to a similar extent as medications, improving GC and reducing the risk of 
hypoglycaemic events [14].
Derdemezis and Loveg [4], reported in by a systematic review that low GI diets effectively 
improve GC. They observed that subjects with T2DM presented significant beneficial effects 
after the consumption of low GI diets; however, in some cases, a low GI diet was associated 
with significant weight reduction, which makes difficult to establish firm conclusions, because 
it is not clear if the effect on the improvement of GC is for the low GI diet per se or derived 
from the weight loss itself. On the other hand, in subjects with T1DM there is insufficient 
evidence for the beneficial effects of GI control due to different confounding factors (differ-
ences in dietary fibre intake and the values used for calculation of dietary GI and weight loss), 
suggesting that total carbohydrate content adjusting pre-meal insulin infusion might be more 
important than GI in controlling postprandial glucose levels. However, low GI diets might be 
used as a treatment in T1DM in order to reduce the insulin infusions. The potential of a low 
GI diet in preventing diabetes has not been studied to date, but low GI diet may improve GC 
and reduce the risk of diabetes and its complications [4].
In another study, T1DM subjects (7–17 years old) were provided with four premade test 
meals, which were consumed at breakfast after a minimum 10 h overnight fast [16]. The low 
GI test meal had a GI of 48, meanwhile the one with high-GI test meal had a GI of 84. For the 
measurement of blood glucose, they used a continuous glucose monitoring system. The low 
GI meal produced significantly lower postprandial glucose excursion (PPGE) for 30–180 min-
utes, lower area under the blood glucose response curve (AUC), a smaller peak blood glucose 
excursion, and reduced time to reach baseline blood glucose levels compared with the high GI 
meal when preprandial ultra-short-acting insulin was administered. Nevertheless, the effect 
of GI on the postprandial glucose response requires further exploration in children receiving 
intensive insulin therapy [16].
A systematic review performed by Thomas and Elliott [2] in T1DM and T2DM children and 
adults, showed that GC in people with diabetes improved significantly with a low GI diet, 
by decreasing hypoglycaemic episodes, compared to those on higher GI diets or measured 
carbohydrate exchange diets. It was observed that a low GI diet produces a decrease of 0.5% 
HbA1c, clinically significant, similar to the reductions produce by the medications given to 
newly diagnosed T2DM subjects; as a result, it has been confirmed that a low GI diet is associ-
ated with a significant reduction in the risk of microvascular complications [2].
In 2010, these authors performed a meta-analysis with evidence that low GI diets significantly 
improve GC, by lowering HbA1c without any increase in the rate of hypoglycaemic episodes, 
when compared with a measured carbohydrate exchange diet and a high-cereal fibre diet. In 
other studies, low GI diet improved HbA1c levels in T1DM children; in contrast, T2DM low 
GI group presented a significant increase in insulin sensitivity compared to the high GI group. 
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The effect is sufficiently strong that may benefit diabetic patients by reducing or even avoid-
ing their requirement for medication [10].
It is important to keep in mind that medications that improve blood glucose levels usually 
are associated with high risk of hypoglycaemia, which is the greatest barrier to achieve an 
optimal GC, particularly in T1DM. In people with T2DM a reduction in HbA1c levels after the 
consumption of low GI diets has been observed, whereas in children with T1DM, with both 
intensive multiple daily injection of insulin or insulin pump therapy, a reduction in postpran-
dial glucose excursions, as well as improvements in insulin sensitivity after 3 to 4 weeks was 
demonstrated. However, a high GI diet worsens insulin resistance in individuals with and 
without diabetes and rises blood glucose levels and the need to medication in T2DM and the 
insulin requirements in T1DM. Therefore, the reduction of the risk of diabetes-related com-
plications with low GI diets is similar to or greater than the diets including a high intake of 
fibre and whole grains [14].
A low GI diets favours slower and more gradual absorption of glucose from the gastrointestinal 
tract, avoiding hypoglycaemic episodes; moreover, it produces fewer stimuli for insulin release, 
reduces free fatty acids levels and oxidative stress, and increases insulin sensitivity [17].
According to the Canadian Diabetes Association, interventions replacing high GI carbohy-
drates with low GI carbohydrates in mixed meals have shown clinically significant improve-
ments in GC over 2 weeks to 6 months in people with T1DM or T2DM; improvements  were 
observed in cardiovascular risk factors, postprandial glycaemia and high sensitivity C-reactive 
protein over 1 year in people with T2DM, whereas adults and children with T1DM showed 
lower hypoglycaemic events over 24 to 52 weeks [20]. In addition, it has been shown that 
low GI diets sustain improved GC and HDL cholesterol compared with a high-cereal fibre 
diet over 6 months, and improved β-cell function in comparison with a low carbohydrate, 
high monounsaturated fat diet over 1 year in people with T2DM [20]. As it has been already 
mentioned, diets with lower GI result in improvements in HbA1c in the order of 0.5%. [19].
In contrast, a review carried out by Madsbad [49] in subjects with T1DM and T2DM showed 
different results. Dietary carbohydrate restriction as early therapy in T2DM, and as an adjunct 
to therapy in T1DM, effectively reduces blood glucose levels. However, longer-term studies 
(≥6 months) have variable results regarding the relative efficacy of low carbohydrate diets 
compared to low in fat or low GI diets on weight and HbA1c reductions. While recent meta-
analyses suggest that low carbohydrate diets may be no more effective over the longer term 
than low fat or Low GI diets, in terms of weight and HbA1c changes [49].
It has been observed a reduction in the risk of diabetes with the consumption of low GI diet, 
whereas high dietary GI and/or glycaemic load increase the risk of T2DM [18]. Observational 
data suggest that replacing high GI with low GI carbohydrate reduces the risk of metabolic 
disturbances and T2DM. Nevertheless, some studies show inconclusive results that may be 
due to methodological differences and confounding parameters that can dramatically modify 
the post-meal metabolic response, such as the type of carbohydrate and its digestibility, quan-
tity of carbohydrates as compared with other macronutrients, lipids, proteins and fibres [18].
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Recent criticisms of the GI claim that GI methodology is not valid, and GI values are inaccu-
rate and imprecise, and GI does not predict what foods are healthy and that whole grain and 
fibre are better markers of carbohydrate quality than GI. Eating a food as part of a mixed meal 
affects the glycaemic response, but does not alter the food’s GI, because is an intrinsic charac-
teristic of food. However, the glycaemic response of a food or a meal is altered in the presence 
of other foods depending on the amount and source (GI) of carbohydrate and the amounts 
and types of fat and protein added. Moreover, it is important to take into account that the 
relative glycaemic response of a meal is determined by its calculated meal GI and the amounts 
of available carbohydrates, fat and protein. Therefore, GI is a valid marker of carbohydrate 
quality because GI methodology is accurate and precise and GI is a property of the food, and 
is biologically meaningful and influences outcomes in health and disease, especially in the 
nutritional management of diabetes. Despite the fact that the results are inconclusive, there is 
no evidence to suggest any negative effect of following low GI diets, which are consistent with 
healthy eating recommendations aimed at weight control and reducing the risk of diabetes-
related complications by improving the GC in people with diabetes (Table 2) [14, 15, 17, 49].
It should be noted that a traditional Mediterranean-style dietary pattern improves GC and car-
diovascular risk factors, including systolic blood pressure, total cholesterol, HDL cholesterol, 
the total cholesterol/HDL cholesterol ratio and triglycerides in T2DM. On the other hand, a 
low carbohydrate Mediterranean-style diet has shown reductions in HbA1c and delays on 
the need for antihyperglycaemic drug therapy at 4 years of diagnosis, compared with low 
fat diet in overweight individuals with newly diagnosed T2DM. To sum up, traditional and 
low carbohydrate Mediterranean-style diets are shown to reduce HbA1c and triglycerides, 
whereas only the low carbohydrate Mediterranean-style diet improves LDL cholesterol and 
HDL cholesterol at 1 year of diagnosis in overweight subjects with T2DM [14, 20].
It has been shown that a disrupted balance between oxidative stress and antioxidant cas-
cades contributes to neuroplasticity deficits in experimental models of diabetes; therefore, 
antioxidants treatments may provide excellent adjunct treatments to traditional approaches 
to reduce the neurological complications of diabetes. In a review carried out by Reagan, the 
neuroplasticity deficits were attenuated or eliminated by antioxidants, including melatonin 
and vitamin E, lycopene, resveratrol, dehydroepiandrosterone (DHEA) and essential fatty 
acids. T2DM patients supplemented with vitamin E and with increasing serum lycopene lev-
els showed reductions in oxidative stress parameters, whereas DHEA administration showed 
reductions in plasma oxidative stress measures and lipid peroxidation products and increased 
antioxidants in T2DM subjects [12].
It is essential to take into account that the nutritional management in children and adoles-
cents is more complex than in adults, because they do not have autonomy or the necessary 
knowledge to maintain a good GC. In a recent study carried out in 282 T1DM children and 
adolescents, a greater nutrition knowledge of parents and patients, measured by a type 1 
diabetes Nutrition Knowledge Survey (NKS), was associated with both better GC and higher 
diet quality in their children. Therefore, it is vital an early nutritional education and the role 
of parents in order to achieve good nutritional management and GC during childhood [48].
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References Low GI diet
T1DM Rahelić, et al. [17] • Lower fasting glucose
• Reduction of oxidative stress
Ryan, et al. [16] • Lower PPGE
• Lower AUC
• Lower peak blood glucose excursion
• Reduced time to reach baseline blood glucose levels
Thomas, et al. [2, 10] Acceptable/ Improved HbA1c levels
Derdemezis, et al [4]; Dworatzek 
et al. [20]
Improved glycaemic control
Thomas, et al. [2]; Marsh et al. [14]; 
Dworatzek et al. [20]
Lower hypoglycaemic events
Marsh et al. [14]; Blaak et al. [18] Reduced postprandial hyperglycaemia
High GI diet
Marsh et al. [14] • Rapid rise in blood glucose and insulin levels
• Increased insulin requirements
• Increased postprandial glycaemia
• Higher hypoglycaemic episodes
References Low GI diet
T2DM Rahelić et al. [17] Lower fasting glucose
Reduction of oxidative stress
Thomas et al. [2]; IDF* [19] Decrease of 0.5% in HbA1c levels
Thomas, et al. [10]; Marsh et al. [14] Increased insulin sensitivity
Thomas, et al. [10] • Reduction or avoidance of diabetic medication
• Significant reduction in BMI, total fat mass and body mass
Thomas, et al. [2]; Derdemezis, et al. 
[2]; Dworatzek et al. [20]
Improved glycaemic control
Thomas, et al. [10]; Marsh et al. [14]; 
Dworatzek et al. [20]
Improvement in lipid profiles (total cholesterol, LDL-c and HDL-c 
levels) and C-reactive protein
Dworatzek et al. [20] • Improvement in CV risk factors
• Improved postprandial glycaemia
Marsh et al. [14] Reduced postprandial hyperglycaemia
Derdemezis, et al. [4];
Thomas, et al. [10]
Significant weight loss in overweight/obese people
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The previous nutritional recommendations are aimed to achieve a good GC and nutritional 
management in the long-term; nonetheless, it is necessary to address the acute dietary com-
plications, meaning the management of hypoglycaemia, because it is the most common acute 
complication of the treatment of T1DM. In case of hypoglycaemia (<60–70 mg/dl) it is neces-
sary an immediate oral, rapidly absorbed, simple carbohydrate to raise blood glucose up to 
100 mg/dl [39].
Finally, the exercise is indispensable in the management of diabetes, especially in T2DM 
children and adolescents, due to this pathology is commonly associated with obesity. The 
American Academy of Paediatrics recommends that health care professionals encourage chil-
dren and adolescents with T2DM to practice moderate to vigorous exercise for at least 60 min-
utes daily and to limit non-academic ‘screen time’, such as watching television or playing 
computer games, to less than 2 hours per day for the reduction of BMI and the improvement 
of GC. Physical activity is an integral part of weight management for the prevention and treat-
ment of T2DM. Although there is scarce available data from children and adolescents with 
T2DM, several well-controlled studies performed in obese children and adolescents at risk of 
metabolic syndrome and T2DM provide guidelines for physical activity [43].
5. Future prospects
Although, the optimal diet and macronutrient composition in diabetes remain controversial 
and the evidence is not sufficiently robust to recommend a low GI diet as the primary dietary 
References Low GI diet
High GI diet
Marsh et al. [14] • Rapid rise in blood glucose and insulin levels
• Increased postprandial glycaemia
• Higher need to medication
• Fasting hypertriglyceridaemia
• Lower HDL-c levels
• Reduced fibrinolysis
Marsh et al. [14]; Rahelić et al. [17] Increased insulin resistance
Marsh et al. [14]; Rahelić et al. [17]; 
Blaak et al. [18]
Increased risk of T2DM up to 40%
Area under the blood glucose response curve, AUC; body mass index, BMI; cardiovascular, CV; glycated haemoglobin 
A1c, HbA1c; high density lipoprotein cholesterol, HDL-c; low density lipoprotein cholesterol, LDL-c; postprandial 
glucose excursion, PPGE; type 1 diabetes mellitus, T1DM; type 2 diabetes mellitus, T2DM*International Diabetes 
Federation.
Table 2. Main effects of low and high glycaemic index diets on the nutritional management of diabetes in children and 
adolescents.
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strategy for GC, low GI diets are high in fibre and whole-grain products, rich in legumes, fruits 
and vegetables with balanced fat profile, low saturated fats and high monounsaturated fatty acids 
(MUFAs) and polyunsaturated fatty acids (PUFAs). Therefore, this nutritional intervention may 
have beneficial effects in diabetics and populations at risk, such as children with T1DM [4, 14]. 
Antioxidant treatments or diets rich in antioxidants may reduce the diabetes-related neuro-
logical complications, when they are used together with traditional treatments [12]. Given 
that there is no optimal diet for the management of GC in subjects with T1DM and T2DM, it 
would be interesting to study the effects of a low GI diet based in a traditional Mediterranean-
diet pattern (rich in vegetables and fruits, high content in antioxidants and fibre), that had 
demonstrated to improve the GC in these subjects, to evaluate the power for preventing cog-
nitive dysfunctions and to optimise the neurodevelopment in children and youth.
It is vital to perform more long-term studies in children and adolescents, especially in those 
with T2DM, due to the increased prevalence in this population, considering the scarce evi-
dence for optimal management of children with T2DM [43]. On the other hand, it is essen-
tial to develop lifestyle interventions in population at risk during childhood and adolescence 
(individualised nutritional and exercise programmes), focused on investigating how to pre-
vent the development of glucose tolerance impairment, and diabetes. These interventions 
could protect against cognitive decline, because they help to achieve GC, reducing hypo and 
hyperglycaemic episodes [44].
Furthermore, the clinical follow-up of T1DM children must include also a survey of neuro-
psychological and brain development to prevent long-lasting consequences.
6. Conclusions
Further research is needed in diabetic children and adolescents, especially well-designed 
long-term randomised controlled trials with larger sample size to determine the true value 
of low GI diets on overall quality of life, long-term GC and the prevention or management 
of diabetes-related complications. The results obtained up to the present moment are incon-
clusive due to discrepancies between the methods of analysis and the diversity in the meth-
odology employed. Therefore, it is difficult to generalise results. It is necessary the use of 
validated questionnaires for the dietary assessment and standardised the GI databases in 
order to make the data comparable between different studies. One limitation of all obser-
vational studies published to date is that none of the food frequency questionnaires have 
been specifically designed to assess the GI and until recently, few were validated against 
another method of dietary assessment, such as 24 h recalls or diet records. Therefore, these 
questionnaires have poor ability to estimate carbohydrate intake, calling into question the 
accuracy of any GI or glycaemic load estimation [14]. On the other hand, the studies use dif-
ferent cognitive tests to assess cognitive domains. Therefore, it is difficult to compare results 
between studies. Brain imaging is becoming essential to clarify the effects of diabetes on 
brain development, and it will offer us new perspectives for the prevention of neurological 
disorders and mental health.
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Covariates that could affect neurocognitive testing and should be taken into account are, 
age, education, sex, history of other chronic illnesses, psychiatric and neurological disorders, 
absence from school, socioeconomic status, and hypo/hyperglycaemia during testing. Most of 
the studies control for at least some of these covariates, but most fail to control all of them [34].
There is wide criticism and controversies about low GI diet. Some authors state that is easy to 
follow and effective, whereas other authors think GI is highly variable, not physiological and 
difficult to learn and follow. Despite this, GI concept is accepted by many diabetes associa-
tions around the world as an integral part of the dietary treatment of diabetes. Despite the 
controversy, there is substantial evidence that a low GI diet can improve the GC in subjects 
with diabetes. It is vital to carry out further research of the role of GI in the prevention and 
treatment of diabetes and its complications together with beneficial effects of a low GI diet 
[17]. One of the major controversies about GI is that different studies state that the GI of food 
change in the presence of other macronutrients, but the reality is that GI is an intrinsic charac-
teristic of food. Therefore, the GI of food does not change in the presence of other macronutri-
ents, such as lipids, proteins and fibre, is just the glycaemic response. It has been shown that 
proteins induce greater insulin secretion, while fats reduce gastric emptying and slow down 
the absorption of carbohydrate. It is essential to study the effects of protein, fat and fibre on 
the glycaemic response to a carbohydrate meal [15], especially in children and adolescents.
On the other hand, nutritional education and physical activity are essential in order to achieve 
a good GC of the disease. The main goal of diabetes management is to prevent long-term 
complications, not only cognitive dysfunction, also micro and macrovascular complications. 
More studies in cognitive function in diabetic children and adolescents with severe hypogly-
caemia are needed, because preventing hypoglycaemia could reduce cognitive dysfunction 
[36], and improve healthy ageing in the diabetic patients. Long-term interventions will help 
also to know the impact of disease duration on cognition. More intensive diabetes medical 
regimes will be associated with less neurocognitive deficits, especially in patients with an 
EOD because they are more expose through time to glycaemic extremes (hypo and hyper-
glycaemias). It is vital to identify the factors that are involved in the aetiology and progres-
sion of the neurological complications, because currently the pathophysiology of cognitive 
dysfunction in diabetes is not well understood [1]. Therefore, it is important to understand 
the pathogenesis of cognitive dysfunction secondary to diabetes in order to establish more 
efficient treatments and prevent or reverse these cognitive alterations [34]. Thus, further well 
designed human studies are needed to elucidate the pathophysiology and the mechanisms of 
action of cognitive dysfunction through neuroimaging [3].
In conclusion, it is necessary to carry out well designed long-term intervention randomised 
control trials with larger sample size, detailed cognitive assessment combined with neuro-
imaging [7] and adequate dietetic management. Furthermore, it is essential an early dietetic 
intervention in order to prevent or reduce diabetes-related complications, especially in chil-
dren and adolescents with an EOD, because they are exposed through time to glycaemic 
extremes and are more vulnerable than adults, because their CNS is developing and any dam-
age could be irreversible. Finally, it is important to identify population at risk during early 
life and childhood in order to develop clear recommendations, prevent the development of 
diabetes and promote healthy ageing.
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ADHD attention deficit hyperactivity disease
AGEs advanced glycation end products
AUC area under the blood glucose response curve
BMI body mass index
CDC Centres for Disease Control
CNS central nervous system
DHEA dehydroepiandrosterone
DM diabetes mellitus
EEG electroencephalography
EOD early onset of diabetes
GC glycaemic control
GDM gestational diabetes mellitus
GI glycaemic index
GPA gluco-psychosocial axis
HbA1c glycated haemoglobin A1c
HDL-c high density lipoprotein cholesterol
HPA hypothalamic-pituitary-adrenal
IQ intelligence quotient
LDL-c low density lipoprotein cholesterol
LOD late onset of diabetes
MUFAs monounsaturated fatty acids
NKS Nutrition Knowledge Survey
PPGE postprandial glucose excursion
PUFAs polyunsaturated fatty acids
T1DM type 1 diabetes mellitus
T2DM type 2 diabetes mellitus
WHO World Health Organisation
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